[
  {
    "ts": null,
    "headline": "STERIS plc (STE) Remains in Focus as Analysts Reaffirm Confidence",
    "summary": "STERIS plc (NYSE:STE) is one of the best medical technology stocks to invest in. On February 5, Citizens reiterated its Market Outperform rating on STERIS plc (NYSE:STE) and kept the $280 price target on the shares. The firm made this move in reaction to STERIS’s Q3 FY2026 financial results. STERIS beat revenue expectations by about […]",
    "url": "https://finnhub.io/api/news?id=a282390f6487017fc7a4e150af65309940821d2dde839f462cf344118d5a2122",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771156417,
      "headline": "STERIS plc (STE) Remains in Focus as Analysts Reaffirm Confidence",
      "id": 139105995,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "STERIS plc (NYSE:STE) is one of the best medical technology stocks to invest in. On February 5, Citizens reiterated its Market Outperform rating on STERIS plc (NYSE:STE) and kept the $280 price target on the shares. The firm made this move in reaction to STERIS’s Q3 FY2026 financial results. STERIS beat revenue expectations by about […]",
      "url": "https://finnhub.io/api/news?id=a282390f6487017fc7a4e150af65309940821d2dde839f462cf344118d5a2122"
    }
  }
]